These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pathways and targets--opposite approaches to success? Blundy K Drug Discov Today; 2012 Mar; 17(5-6):183-4. PubMed ID: 22138262 [No Abstract] [Full Text] [Related]
4. Modeling neurodegenerative diseases using stem cells: is it accelerating drug discovery? Ebert AD Future Med Chem; 2012 Sep; 4(13):1651-3. PubMed ID: 22924501 [No Abstract] [Full Text] [Related]
5. Biomarkers of Brain Structure and Function for Neurodegenerative Disorders: Are They Adequate for Go/No Go Decisions in Drug Development? Potter WZ Clin Pharmacol Ther; 2015 Nov; 98(5):472-4. PubMed ID: 26418882 [TBL] [Abstract][Full Text] [Related]
6. Drug discovery for neurodegenerative diseases: challenges and novel biochemical targets dedicated to the memory of Mark A. Smith for his inspiring contribution to Alzheimer's disease. Britton GB; Smith MA; Perry G; Sambamurti K; Jagannatha Rao KS J Alzheimers Dis; 2011; 24 Suppl 2():1-2. PubMed ID: 21525570 [No Abstract] [Full Text] [Related]
7. Targeting the 26S Proteasome To Protect Against Proteotoxic Diseases. Myeku N; Duff KE Trends Mol Med; 2018 Jan; 24(1):18-29. PubMed ID: 29233753 [TBL] [Abstract][Full Text] [Related]
8. Targeted drug development for arthritis. Malemud CJ Future Med Chem; 2012 Apr; 4(6):701-3. PubMed ID: 22530633 [No Abstract] [Full Text] [Related]
9. Multitarget network strategies to influence memory and forgetting: the Ras/MAPK pathway as a novel option. Gyurkó MD; Steták A; Sőti C; Csermely P Mini Rev Med Chem; 2015; 15(8):696-704. PubMed ID: 25694072 [TBL] [Abstract][Full Text] [Related]
10. Blocking the mTOR pathway: a drug discovery perspective. Garcia-Echeverria C Biochem Soc Trans; 2011 Apr; 39(2):451-5. PubMed ID: 21428918 [TBL] [Abstract][Full Text] [Related]
11. An insight review of autophagy biology and neurodegenerative diseases: machinery, mechanisms and regulation. Li S; Le W Sci China Life Sci; 2017 Dec; 60(12):1457-1459. PubMed ID: 29285716 [No Abstract] [Full Text] [Related]
13. Translation of developmental biology into therapeutics: the hedgehog signaling pathway and neurodegenerative diseases. Allendoerfer KL; Dudek H Curr Opin Investig Drugs; 2002 Dec; 3(12):1742-4. PubMed ID: 12528310 [No Abstract] [Full Text] [Related]
14. Cell cycle checkpoints: the role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases. Golubnitschaja O Amino Acids; 2007; 32(3):359-71. PubMed ID: 17136506 [TBL] [Abstract][Full Text] [Related]
15. The emerging technologies of neural xenografting and stem cell transplantation for treating neurodegenerative disorders. Emerich DF Drugs Today (Barc); 2004 Mar; 40(3):271. PubMed ID: 15148535 [No Abstract] [Full Text] [Related]
16. Nicotinic acetylcholine receptors as therapeutic targets: Emerging frontiers in basic research and clinical science--Editorial Comments. Dani JA; Donnelly-Roberts D; Bertrand D Biochem Pharmacol; 2015 Oct; 97(4):351. PubMed ID: 26074266 [No Abstract] [Full Text] [Related]
17. Translating protein phosphatase research into treatments for neurodegenerative diseases. Sundaram JR; Lee IC; Shenolikar S Biochem Soc Trans; 2017 Feb; 45(1):101-112. PubMed ID: 28202663 [TBL] [Abstract][Full Text] [Related]
18. [Discovery of drug targets and seeds by 'humanized yeast' technology]. Mizukami T; Kunoh T; Sasaki R Nihon Rinsho; 2012 Nov; 70 Suppl 8():308-15. PubMed ID: 23513857 [No Abstract] [Full Text] [Related]
19. New avenues to target Wnt/β-catenin signaling. Verkaar F; Zaman GJ Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060 [TBL] [Abstract][Full Text] [Related]
20. Highlight: Perspectives of molecular neuroscience in health and disease. Heumann R Biol Chem; 2016 Mar; 397(3):175. PubMed ID: 26812788 [No Abstract] [Full Text] [Related] [Next] [New Search]